{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:12:44Z","timestamp":1787062364378,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Hippo-YAP signaling pathway is a critical regulator of proliferation, apoptosis, and cell fate. The main downstream effector of this pathway, YAP, has been shown to be misregulated in human cancer and has emerged as an attractive target for therapeutics. A significant insufficiency in our understanding of the pathway is the identity of transcriptional targets of YAP that drive its potent growth phenotypes. Here, using liver cancer as a model, we identify NUAK2 as an essential mediator of YAP-driven hepatomegaly and tumorigenesis in vivo. By evaluating several human cancer cell lines we determine that NUAK2 is selectively required for YAP-driven growth. Mechanistically, we found that NUAK2 participates in a feedback loop to maximize YAP activity via promotion of actin polymerization and myosin activity. Additionally, pharmacological inactivation of NUAK2 suppresses YAP-dependent cancer cell proliferation and liver overgrowth. Importantly, our work here identifies a specific, potent, and actionable target for YAP-driven malignancies.<\/jats:p>","DOI":"10.1038\/s41467-018-07394-5","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T10:47:51Z","timestamp":1542019671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["NUAK2 is a critical YAP target in liver cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Wei-Chien","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Pepe-Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio G.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1926-4204","authenticated-orcid":false,"given":"Michael T.","family":"Dill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Tsang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-286X","authenticated-orcid":false,"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele A.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando D.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"7394_CR1","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054\u20132060 (2007).","journal-title":"Curr. Biol."},{"key":"7394_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 16, 425\u2013438 (2009).","journal-title":"Cancer Cell."},{"key":"7394_CR3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1101\/gad.1938710","volume":"24","author":"S Benhamouche","year":"2010","unstructured":"Benhamouche, S. et al. Nf2\/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev. 24, 1718\u20131730 (2010).","journal-title":"Genes Dev."},{"key":"7394_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437\u20131442 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7394_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/dvdy.21996","volume":"238","author":"M Kango-Singh","year":"2009","unstructured":"Kango-Singh, M. & Singh, A. Regulation of organ size: insights from the Drosophila Hippo signaling pathway. Dev. Dyn. 238, 1627\u20131637 (2009).","journal-title":"Dev. Dyn."},{"key":"7394_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by LATS and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev. 24, 72\u201385 (2010).","journal-title":"Genes Dev."},{"key":"7394_CR7","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-07-6205","volume":"68","author":"J Zhang","year":"2008","unstructured":"Zhang, J., Smolen, G. A. & Haber, D. A. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res. 68, 2789\u20132794 (2008).","journal-title":"Cancer Res."},{"key":"7394_CR8","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496\u20135509 (2008).","journal-title":"J. Biol. Chem."},{"key":"7394_CR9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"7394_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tcb.2012.04.006","volume":"22","author":"A Ramos","year":"2012","unstructured":"Ramos, A. & Camargo, F. D. The Hippo signaling pathway and stem cell biology. Trends Cell Biol. 22, 339\u2013346 (2012).","journal-title":"Trends Cell Biol."},{"key":"7394_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S. et al. Role of YAP\/TAZ in mechanotransduction. Nature 474, 179\u2013183 (2011).","journal-title":"Nature"},{"key":"7394_CR12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/emboj.2011.157","volume":"30","author":"L Sansores-Garcia","year":"2011","unstructured":"Sansores-Garcia, L. et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325\u20132335 (2011).","journal-title":"EMBO J."},{"key":"7394_CR13","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1242\/dev.070987","volume":"138","author":"K Wada","year":"2011","unstructured":"Wada, K., Itoga, K., Okano, T., Yonemura, S. & Sasaki, H. Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907\u20133914 (2011).","journal-title":"Development"},{"key":"7394_CR14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120\u20131133 (2007).","journal-title":"Cell"},{"key":"7394_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1101\/gad.233676.113","volume":"28","author":"Q Chen","year":"2014","unstructured":"Chen, Q. et al. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis. Genes Dev. 28, 432\u2013437 (2014).","journal-title":"Genes Dev."},{"key":"7394_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.cell.2011.02.031","volume":"144","author":"K Schlegelmilch","year":"2011","unstructured":"Schlegelmilch, K. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782\u2013795 (2011).","journal-title":"Cell"},{"key":"7394_CR17","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2005049","volume":"7","author":"W Zhang","year":"2014","unstructured":"Zhang, W. et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci. Signal. 7, ra42 (2014).","journal-title":"Sci. Signal."},{"key":"7394_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP\/TAZ at the roots of cancer. Cancer Cell. 29, 783\u2013803 (2016).","journal-title":"Cancer Cell."},{"issue":"10","key":"7394_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","volume":"10","author":"Julien Fitamant","year":"2015","unstructured":"Fitamant, J. et al. YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep. 10, 1692\u20131707 (2015).","journal-title":"Cell Reports"},{"key":"7394_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246\u2013257 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"7394_CR21","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"M Overholtzer","year":"2006","unstructured":"Overholtzer, M. et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl Acad. Sci. USA 103, 12405\u201312410 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7394_CR22","doi-asserted-by":"publisher","first-page":"e91770","DOI":"10.1371\/journal.pone.0091770","volume":"9","author":"Y Xia","year":"2014","unstructured":"Xia, Y. et al. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PLoS ONE 9, e91770 (2014).","journal-title":"PLoS One"},{"key":"7394_CR23","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-10-2467","volume":"17","author":"W Kang","year":"2011","unstructured":"Kang, W. et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin. Cancer Res. 17, 2130\u20132139 (2011).","journal-title":"Clin. Cancer Res."},{"key":"7394_CR24","doi-asserted-by":"publisher","first-page":"17206","DOI":"10.18632\/oncotarget.4043","volume":"6","author":"T Pei","year":"2015","unstructured":"Pei, T. et al. YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget 6, 17206\u201317220 (2015).","journal-title":"Oncotarget"},{"key":"7394_CR25","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300\u20131305 (2012).","journal-title":"Genes Dev."},{"key":"7394_CR26","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/ncb1993","volume":"11","author":"J Zhang","year":"2009","unstructured":"Zhang, J. et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat. Cell Biol. 11, 1444\u20131450 (2009).","journal-title":"Nat. Cell Biol."},{"key":"7394_CR27","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1541-7786.MCR-12-0665","volume":"11","author":"EY Ahn","year":"2013","unstructured":"Ahn, E. Y., Kim, J. S., Kim, G. J. & Park, Y. N. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Mol. Cancer Res. 11, 748\u2013758 (2013).","journal-title":"Mol. Cancer Res."},{"key":"7394_CR28","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/onc.2010.504","volume":"30","author":"MZ Xu","year":"2011","unstructured":"Xu, M. Z. et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30, 1229\u20131240 (2011).","journal-title":"Oncogene"},{"key":"7394_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hep.28223","volume":"63","author":"YY Park","year":"2016","unstructured":"Park, Y. Y. et al. Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology 63, 159\u2013172 (2016).","journal-title":"Hepatology"},{"key":"7394_CR30","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747\u20132761 (2007).","journal-title":"Genes Dev."},{"key":"7394_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molcel.2015.09.001","volume":"60","author":"GG Galli","year":"2015","unstructured":"Galli, G. G. et al. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol. Cell 60, 328\u2013337 (2015).","journal-title":"Mol. Cell"},{"key":"7394_CR32","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/JME-13-0063","volume":"51","author":"X Sun","year":"2013","unstructured":"Sun, X., Gao, L., Chien, H. Y., Li, W. C. & Zhao, J. The regulation and function of the NUAK family. J. Mol. Endocrinol. 51, R15\u201322 (2013).","journal-title":"J. Mol. Endocrinol."},{"key":"7394_CR33","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1038\/sj.onc.1210878","volume":"26","author":"U Fischer","year":"2007","unstructured":"Fischer, U. & Meese, E. Glioblastoma multiforme: the role of DSB repair between genotype and phenotype. Oncogene 26, 7809\u20137815 (2007).","journal-title":"Oncogene"},{"key":"7394_CR34","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1073\/pnas.1007694108","volume":"108","author":"T Namiki","year":"2011","unstructured":"Namiki, T. et al. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma. Proc. Natl Acad. Sci. USA 108, 6597\u20136602 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7394_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-013-2408-2","volume":"138","author":"B Mesquita","year":"2013","unstructured":"Mesquita, B. et al. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes. Breast Cancer Res. Treat. 138, 37\u201345 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"7394_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1349-7006.2008.00734.x","volume":"99","author":"K Tsuchihara","year":"2008","unstructured":"Tsuchihara, K. et al. Susceptibility of Snark-deficient mice to azoxymethane-induced colorectal tumorigenesis and the formation of aberrant crypt foci. Cancer Sci. 99, 677\u2013682 (2008).","journal-title":"Cancer Sci."},{"key":"7394_CR37","doi-asserted-by":"publisher","first-page":"e1005465","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein, C. et al. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet. 11, e1005465 (2015).","journal-title":"PLoS Genet."},{"key":"7394_CR38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F. et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 17, 1218\u20131227 (2015).","journal-title":"Nat. Cell Biol."},{"key":"7394_CR39","doi-asserted-by":"crossref","unstructured":"Lin, C. et al. YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis. Elife 6,\u00a0e21130 (2017).","DOI":"10.7554\/eLife.21130"},{"key":"7394_CR40","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"7394_CR41","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"D Yimlamai","year":"2014","unstructured":"Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324\u20131338 (2014).","journal-title":"Cell"},{"key":"7394_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbrc.2007.11.013","volume":"365","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto, H. et al. Identification of a novel substrate for TNFalpha-induced kinase NUAK2. Biochem. Biophys. Res. Commun. 365, 541\u2013547 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7394_CR43","doi-asserted-by":"publisher","first-page":"ra25","DOI":"10.1126\/scisignal.2000616","volume":"3","author":"A Zagorska","year":"2010","unstructured":"Zagorska, A. et al. New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci. Signal. 3, ra25 (2010).","journal-title":"Sci. Signal."},{"key":"7394_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ncb2884","volume":"16","author":"M Mohseni","year":"2014","unstructured":"Mohseni, M. et al. A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat. Cell Biol. 16, 108\u2013117 (2014).","journal-title":"Nat. Cell Biol."},{"key":"7394_CR45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell 154, 1047\u20131059 (2013).","journal-title":"Cell"},{"key":"7394_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/ncb2756","volume":"15","author":"F Calvo","year":"2013","unstructured":"Calvo, F. et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637\u2013646 (2013).","journal-title":"Nat. Cell Biol."},{"key":"7394_CR47","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1242\/dev.063545","volume":"138","author":"BG Fernandez","year":"2011","unstructured":"Fernandez, B. G. et al. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138, 2337\u20132346 (2011).","journal-title":"Development"},{"key":"7394_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1432-1033.1992.tb17508.x","volume":"210","author":"D Alessi","year":"1992","unstructured":"Alessi, D., MacDougall, L. K., Sola, M. M., Ikebe, M. & Cohen, P. The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur. J. Biochem. 210, 1023\u20131035 (1992).","journal-title":"Eur. J. Biochem."},{"key":"7394_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1005385302064","volume":"19","author":"DJ Hartshorne","year":"1998","unstructured":"Hartshorne, D. J., Ito, M. & Erdodi, F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J. Muscle Res. Cell Motil. 19, 325\u2013341 (1998).","journal-title":"J. Muscle Res. Cell Motil."},{"key":"7394_CR50","doi-asserted-by":"publisher","first-page":"21209","DOI":"10.1074\/jbc.M102615200","volume":"276","author":"I Tan","year":"2001","unstructured":"Tan, I., Ng, C. H., Lim, L. & Leung, T. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J. Biol. Chem. 276, 21209\u201321216 (2001).","journal-title":"J. Biol. Chem."},{"key":"7394_CR51","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1016\/S0021-9258(17)42855-9","volume":"259","author":"JR Sellers","year":"1984","unstructured":"Sellers, J. R. & Pato, M. D. The binding of smooth muscle myosin light chain kinase and phosphatases to actin and myosin. J. Biol. Chem. 259, 7740\u20137746 (1984).","journal-title":"J. Biol. Chem."},{"key":"7394_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1042\/BJ20131152","volume":"457","author":"S Banerjee","year":"2014","unstructured":"Banerjee, S. et al. Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases. Biochem. J. 457, 215\u2013225 (2014).","journal-title":"Biochem. J."},{"key":"7394_CR53","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1111\/febs.13534","volume":"282","author":"T Monteverde","year":"2015","unstructured":"Monteverde, T., Muthalagu, N., Port, J. & Murphy, D. J. Evidence of cancer-promoting roles for AMPK and related kinases. FEBS J. 282, 4658\u20134671 (2015).","journal-title":"FEBS J."},{"key":"7394_CR54","first-page":"6091","volume":"59","author":"MJ Riemenschneider","year":"1999","unstructured":"Riemenschneider, M. J. et al. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res. 59, 6091\u20136096 (1999).","journal-title":"Cancer Res."},{"key":"7394_CR55","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/0008-5472.CAN-13-3209","volume":"75","author":"T Namiki","year":"2015","unstructured":"Namiki, T. et al. NUAK2 amplification coupled with PTEN deficiency promotes melanoma development via CDK activation. Cancer Res. 75, 2708\u20132715 (2015).","journal-title":"Cancer Res."},{"key":"7394_CR56","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3892\/etm.2016.3983","volume":"13","author":"L Tang","year":"2017","unstructured":"Tang, L. et al. Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells. Exp. Ther. Med. 13, 676\u2013680 (2017).","journal-title":"Exp. Ther. Med."},{"key":"7394_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbagen.2005.03.015","volume":"1724","author":"DL Lefebvre","year":"2005","unstructured":"Lefebvre, D. L. & Rosen, C. F. Regulation of SNARK activity in response to cellular stresses. Biochim. Biophys. Acta 1724, 71\u201385 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"7394_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3550297","volume":"355","author":"DL Lefebvre","year":"2001","unstructured":"Lefebvre, D. L. et al. Identification and characterization of a novel sucrose-non-fermenting protein kinase\/AMP-activated protein kinase-related protein kinase, SNARK. Biochem. J. 355, 297\u2013305 (2001).","journal-title":"Biochem. J."},{"key":"7394_CR59","doi-asserted-by":"publisher","first-page":"352ra108","DOI":"10.1126\/scitranslmed.aaf2304","volume":"8","author":"F Fan","year":"2016","unstructured":"Fan, F. et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci. Transl. Med. 8, 352ra108 (2016).","journal-title":"Sci. Transl. Med."},{"key":"7394_CR60","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.262816.115","volume":"29","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T. et al. A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev. 29, 1271\u20131284 (2015).","journal-title":"Genes Dev."},{"key":"7394_CR61","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/cr.2015.101","volume":"25","author":"X Dai","year":"2015","unstructured":"Dai, X. et al. YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 25, 1175\u20131178 (2015).","journal-title":"Cell Res."},{"key":"7394_CR62","doi-asserted-by":"crossref","first-page":"24063","DOI":"10.18632\/oncotarget.8211","volume":"7","author":"GS Park","year":"2016","unstructured":"Park, G. S. et al. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2. Oncotarget 7, 24063\u201324075 (2016).","journal-title":"Oncotarget"},{"key":"7394_CR63","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2015.98","volume":"25","author":"S Shen","year":"2015","unstructured":"Shen, S. et al. A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis. Cell Res. 25, 997\u20131012 (2015).","journal-title":"Cell Res."},{"key":"7394_CR64","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1172\/JCI73742","volume":"124","author":"J Li","year":"2014","unstructured":"Li, J. et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J. Clin. Invest. 124, 3241\u20133251 (2014).","journal-title":"J. Clin. Invest."},{"key":"7394_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-182","volume":"15","author":"H Jiang","year":"2014","unstructured":"Jiang, H., Lei, R., Ding, S. W. & Zhu, S. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinforma. 15, 182 (2014).","journal-title":"BMC Bioinforma."},{"key":"7394_CR66","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"7394_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"7394_CR68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4939-0512-6_5","volume":"1150","author":"S Xu","year":"2014","unstructured":"Xu, S., Grullon, S., Ge, K. & Peng, W. Spatial clustering for identification of ChIP-enriched regions (SICER) to map regions of histone methylation patterns in embryonic stem cells. Methods Mol. Biol. 1150, 97\u2013111 (2014).","journal-title":"Methods Mol. Biol."},{"key":"7394_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-237","volume":"11","author":"LJ Zhu","year":"2010","unstructured":"Zhu, L. J. et al. ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinforma. 11, 237 (2010).","journal-title":"BMC Bioinforma."},{"key":"7394_CR70","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"7394_CR71","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler, S. et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70, 10202\u201310212 (2010).","journal-title":"Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07394-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07394-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07394-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T15:15:47Z","timestamp":1671549347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07394-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7394"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07394-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4834"}}